143 related articles for article (PubMed ID: 18783335)
1. Immunohistochemical evidence of ubiquitous distribution of the metalloendoprotease insulin-degrading enzyme (IDE; insulysin) in human non-malignant tissues and tumor cell lines.
Weirich G; Mengele K; Yfanti C; Gkazepis A; Hellmann D; Welk A; Giersig C; Kuo WL; Rosner MR; Tang WJ; Schmitt M
Biol Chem; 2008 Nov; 389(11):1441-5. PubMed ID: 18783335
[TBL] [Abstract][Full Text] [Related]
2. Expression of metalloprotease insulin-degrading enzyme insulysin in normal and malignant human tissues.
Yfanti C; Mengele K; Gkazepis A; Weirich G; Giersig C; Kuo WL; Tang WJ; Rosner M; Schmitt M
Int J Mol Med; 2008 Oct; 22(4):421-31. PubMed ID: 18813847
[TBL] [Abstract][Full Text] [Related]
3. Insulin-degrading enzyme is differentially expressed and developmentally regulated in various rat tissues.
Kuo WL; Montag AG; Rosner MR
Endocrinology; 1993 Feb; 132(2):604-11. PubMed ID: 7678795
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical demonstration of the zinc metalloprotease insulin-degrading enzyme in normal and malignant human breast: correlation with tissue insulin levels.
Radulescu RT; Hufnagel C; Luppa P; Hellebrand H; Kuo WL; Rosner MR; Harbeck N; Giersig C; Meindl A; Schmitt M; Weirich G
Int J Oncol; 2007 Jan; 30(1):73-80. PubMed ID: 17143514
[TBL] [Abstract][Full Text] [Related]
5. Effects of Fasting and Feeding on Transcriptional and Posttranscriptional Regulation of Insulin-Degrading Enzyme in Mice.
González-Casimiro CM; Cámara-Torres P; Merino B; Diez-Hermano S; Postigo-Casado T; Leissring MA; Cózar-Castellano I; Perdomo G
Cells; 2021 Sep; 10(9):. PubMed ID: 34572095
[TBL] [Abstract][Full Text] [Related]
6. Natural regulatory mechanisms of insulin degradation by insulin degrading enzyme.
Akiyama H; Yokono K; Shii K; Ogawa W; Taniguchi H; Baba S; Kasuga M
Biochem Biophys Res Commun; 1990 Aug; 170(3):1325-30. PubMed ID: 2202301
[TBL] [Abstract][Full Text] [Related]
7. Modulation of insulin degrading enzyme activity and liver cell proliferation.
Pivovarova O; von Loeffelholz C; Ilkavets I; Sticht C; Zhuk S; Murahovschi V; Lukowski S; Döcke S; Kriebel J; de las Heras Gala T; Malashicheva A; Kostareva A; Lock JF; Stockmann M; Grallert H; Gretz N; Dooley S; Pfeiffer AF; Rudovich N
Cell Cycle; 2015; 14(14):2293-300. PubMed ID: 25945652
[TBL] [Abstract][Full Text] [Related]
8. Insulin-degrading enzyme (IDE): a novel heat shock-like protein.
Tundo GR; Sbardella D; Ciaccio C; Bianculli A; Orlandi A; Desimio MG; Arcuri G; Coletta M; Marini S
J Biol Chem; 2013 Jan; 288(4):2281-9. PubMed ID: 23188819
[TBL] [Abstract][Full Text] [Related]
9. Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2).
Bai JP; Hsu MJ; Shier WT
Pharm Res; 1995 Apr; 12(4):513-7. PubMed ID: 7596985
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical studies on the insulin-degrading enzyme from pig and rat skeletal muscle.
Yokono K; Imamura Y; Shii K; Mizuno N; Sakai H; Baba S
Diabetes; 1980 Oct; 29(10):856-9. PubMed ID: 6777221
[TBL] [Abstract][Full Text] [Related]
11. Glucose inhibits the insulin-induced activation of the insulin-degrading enzyme in HepG2 cells.
Pivovarova O; Gögebakan O; Pfeiffer AF; Rudovich N
Diabetologia; 2009 Aug; 52(8):1656-64. PubMed ID: 19396426
[TBL] [Abstract][Full Text] [Related]
12. Androgen- and estrogen-dependent regulation of insulin-degrading enzyme in subcellular fractions of rat prostate and uterus.
Udrisar DP; Wanderley MI; Porto RC; Cardoso CL; Barbosa MC; Camberos MC; Cresto JC
Exp Biol Med (Maywood); 2005 Jul; 230(7):479-86. PubMed ID: 15985623
[TBL] [Abstract][Full Text] [Related]
13. Alternative splicing of human insulin-degrading enzyme yields a novel isoform with a decreased ability to degrade insulin and amyloid beta-protein.
Farris W; Leissring MA; Hemming ML; Chang AY; Selkoe DJ
Biochemistry; 2005 May; 44(17):6513-25. PubMed ID: 15850385
[TBL] [Abstract][Full Text] [Related]
14. Affinity purification of insulin-degrading enzyme and its endogenous inhibitor from rat liver.
Ogawa W; Shii K; Yonezawa K; Baba S; Yokono K
J Biol Chem; 1992 Jan; 267(2):1310-6. PubMed ID: 1730651
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6 increases the expression and activity of insulin-degrading enzyme.
Kurauti MA; Costa-Júnior JM; Ferreira SM; Santos GJ; Sponton CHG; Carneiro EM; Telles GD; Chacon-Mikahil MPT; Cavaglieri CR; Rezende LF; Boschero AC
Sci Rep; 2017 Apr; 7():46750. PubMed ID: 28429777
[TBL] [Abstract][Full Text] [Related]
16. Reduced neuronal expression of insulin-degrading enzyme in the dorsolateral prefrontal cortex of patients with haloperidol-treated, chronic schizophrenia.
Bernstein HG; Ernst T; Lendeckel U; Bukowska A; Ansorge S; Stauch R; Have ST; Steiner J; Dobrowolny H; Bogerts B
J Psychiatr Res; 2009 Sep; 43(13):1095-105. PubMed ID: 19394958
[TBL] [Abstract][Full Text] [Related]
17. Cellular localization of insulin-degrading enzyme in rat liver using monoclonal antibodies specific for this enzyme.
Akiyama H; Shii K; Yokono K; Yonezawa K; Sato S; Watanabe K; Baba S
Biochem Biophys Res Commun; 1988 Sep; 155(2):914-22. PubMed ID: 3048264
[TBL] [Abstract][Full Text] [Related]
18. Developmental regulation of an insulin-degrading enzyme from Drosophila melanogaster.
Stoppelli MP; Garcia JV; Decker SJ; Rosner MR
Proc Natl Acad Sci U S A; 1988 May; 85(10):3469-73. PubMed ID: 3130628
[TBL] [Abstract][Full Text] [Related]
19. Identification of the metal associated with the insulin degrading enzyme.
Ebrahim A; Hamel FG; Bennett RG; Duckworth WC
Biochem Biophys Res Commun; 1991 Dec; 181(3):1398-406. PubMed ID: 1764090
[TBL] [Abstract][Full Text] [Related]
20. Regulation of protein degradation by insulin-degrading enzyme: analysis by small interfering RNA-mediated gene silencing.
Fawcett J; Permana PA; Levy JL; Duckworth WC
Arch Biochem Biophys; 2007 Dec; 468(1):128-33. PubMed ID: 17964527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
